1. Investor Relations


Investor Relations

Corporate Profile

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients.

With headquarters in Rostock, Germany and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis.

We are active in research and are constantly developing new and innovative products for human genetics. We are focused on helping to end the diagnostic odyssey of our patients by offering the broadest genetic diagnostic portfolio, and on using our global knowledge of rare hereditary diseases to provide solutions for our pharmaceutical partners that accelerate the development of orphan drugs.

We are committed to ‘un-rare’ rare diseases by using our worldwide knowledge in the rare disease market, understanding the epidemiology, analyzing clinical heterogeneity of the more than 3800 diseases and developing innovative biomarkers. Based on this knowledge we are bringing rationality to treatment decisions and, thereby, accelerate the development of new orphan drugs.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
May 10, 2021
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of disease progression,
May 06, 2021
CENTOGENE’s rare disease mutation database offers new features and previously unpublished variants Database has grown to more than 465,000 analyzed patients, with more than 225,000 being linked to HPO terms Release includes increase of almost 19 million to over 31 million unique variants New
Featured Publications